ProShares UltraShort Nasdaq Biotechnology
BIS
NASDAQ
| Weiss Ratings | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Valuation | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $12.22 | |||
| Company Info | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | ProShares | |||
| Manager/Tenure (Years) | Michael Neches (13), Tarak Davé (8) | |||
| Website | http://www.proshares.com | |||
| Phone Number | 866-776-5125 | |||
| Fund Information | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | ProShares UltraShort Nasdaq Biotechnology | |||
| Category | Trading--Inverse Equity | |||
| Sub-Category | Trading Tools | |||
| Prospectus Objective | Specialty - Technology | |||
| Inception Date | Apr 06, 2010 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 5.53% | |||
| Dividend | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | -- | |||
| Asset Allocation | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 199.94% | |||
| Stock | -199.94% | |||
| U.S. Stock | -199.94% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 100.00% | |||
| Price History | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 8.57% | |||
| 30-Day Total Return | 14.57% | |||
| 60-Day Total Return | -12.40% | |||
| 90-Day Total Return | -3.11% | |||
| Year to Date Total Return | -33.54% | |||
| 1-Year Total Return | -47.32% | |||
| 2-Year Total Return | -57.87% | |||
| 3-Year Total Return | -70.79% | |||
| 5-Year Total Return | -63.14% | |||
| Price | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $11.71 | |||
| 1-Month Low Price | $10.79 | |||
| 1-Month High Price | $12.10 | |||
| 52-Week Low Price | $10.53 | |||
| 52-Week Low Price (Date) | Aug 19, 2026 | |||
| 52-Week High Price | $24.35 | |||
| 52-Week High Price (Date) | Oct 10, 2025 | |||
| NAV | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $10.79 | |||
| 1-Month High NAV | $12.09 | |||
| 52-Week Low NAV | $10.51 | |||
| 52-Week Low NAV (Date) | Aug 19, 2026 | |||
| 52-Week High NAV | $24.34 | |||
| 52-Week High Price (Date) | Oct 10, 2025 | |||
| Beta / Standard Deviation | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.65 | |||
| Standard Deviation | 33.17 | |||
| Balance Sheet | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.85M | |||
| Operating Ratios | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.95% | |||
| Turnover Ratio | 0.00% | |||
| Performance | BIS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | -51.60% | |||
| Last Bear Market Total Return | 11.86% | |||